XML 39 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Loss)
Treasury Stock
Non-Controlling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common Stock, Shares, Outstanding   80,557          
Common Stock, Value, Issued   $ 8          
Additional paid-in capital     $ 495,999        
Retained earnings       $ 1,421,067      
Accumulated other comprehensive loss         $ (29,544)    
Treasury stock, shares           53,472  
Treasury Stock, Value           $ (1,075,432)  
Noncontrolling interest             $ 8,440
Share repurchases and net settlement of awards under stock plan (in shares)   (4,188)       (4,188)  
Share repurchases and net settlement of restricted stock awards $ (148,878)         $ (148,878)  
Exercise of stock options (in Shares)   24          
Exercise and net settlement of stock options 602   602        
Issuance of fully vested restricted stock (in Shares)   403          
Stock-based compensation 24,396   24,396        
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent         (5,616)    
Foreign currency translation adjustment (6,681)           (1,065)
Unrealized Gain (Loss) on Cash Flow Hedging Instruments (549)       (549)    
Dividends, Common Stock, Cash (66,005)     (66,005)      
Noncontrolling Interest, Increase from Business Combination (294)           (294)
Noncontrolling Interest, Increase from Business Combination 2,500           2,500
Net loss attributable to noncontrolling interests 1,156           1,156
Proceeds from sales of business 1,017   (556)       1,573
Net income       216,061      
Net income 217,217            
Balance at Dec. 31, 2022 843,863            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common Stock, Shares, Outstanding   76,796          
Common Stock, Value, Issued   $ 8          
Additional paid-in capital     520,441        
Retained earnings       1,571,123      
Accumulated other comprehensive loss         (35,709)    
Treasury stock, shares           57,660  
Treasury Stock, Value           $ (1,224,310)  
Noncontrolling interest             12,310
Share repurchases and net settlement of awards under stock plan (in shares)   (3,730)       (3,730)  
Share repurchases and net settlement of restricted stock awards $ (133,628) $ 1       $ (133,627)  
Exercise of stock options (in Shares) 1,654 254       1,400  
Exercise and net settlement of stock options $ (7,515)   41,566     $ (49,081)  
Issuance of fully vested restricted stock (in Shares)   361          
Stock-based compensation 24,148   24,148        
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent         7,292    
Foreign currency translation adjustment 7,611           319
Unrealized Gain (Loss) on Cash Flow Hedging Instruments (629)       (629)    
Dividends, Common Stock, Cash (63,177)     (63,177)      
Noncontrolling Interest, Increase from Business Combination 4,486           4,486
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders (1,102)           (1,102)
Net loss attributable to noncontrolling interests 2,421           2,421
Net income       171,554      
Net income 173,975            
Balance at Dec. 31, 2023 $ 848,032            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common Stock, Shares, Outstanding 73,681 73,681          
Common Stock, Value, Issued $ 7 $ 7          
Additional paid-in capital 586,155   586,155        
Retained earnings 1,679,500     1,679,500      
Accumulated other comprehensive loss $ (29,046)       (29,046)    
Treasury stock, shares 62,790         62,790  
Treasury Stock, Value $ (1,407,018)         $ (1,407,018)  
Noncontrolling interest 18,434           18,434
Share repurchases and net settlement of awards under stock plan (in shares)   (2,280)       (2,280)  
Share repurchases and net settlement of restricted stock awards $ (98,321)         $ (98,321)  
Exercise of stock options (in Shares) 73 52       21  
Exercise and net settlement of stock options $ 1,502   2,392     $ (890)  
Issuance of fully vested restricted stock (in Shares)   704          
Stock-based compensation 26,539   26,539        
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent         (21,069)    
Foreign currency translation adjustment (21,993)           (924)
Unrealized Gain (Loss) on Cash Flow Hedging Instruments 1,824       1,824    
Dividends, Common Stock, Cash (61,039)     (61,039)      
Noncontrolling Interest, Increase from Business Combination 4,949           4,949
Noncontrolling Interest, Period Increase (Decrease) (1,500)   (705)       (795)
Noncontrolling Interest, Increase from Sale of Parent Equity Interest 102           102
Net loss attributable to noncontrolling interests 6,512           6,512
Proceeds from sales of business 1,017            
Net income       169,390      
Net income 175,902            
Balance at Dec. 31, 2024 $ 875,997            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common Stock, Shares, Outstanding 72,157 72,157          
Common Stock, Value, Issued $ 7 $ 7          
Additional paid-in capital 614,381   $ 614,381        
Retained earnings 1,787,851     $ 1,787,851      
Accumulated other comprehensive loss $ (48,291)       $ (48,291)    
Treasury stock, shares 65,091         65,091  
Treasury Stock, Value $ (1,506,229)         $ (1,506,229)  
Noncontrolling interest $ 28,278           $ 28,278